Clinical relevance of the ESKAPE pathogens
Publication type: Journal Article
Publication date: 2013-03-04
scimago Q1
wos Q1
SJR: 1.090
CiteScore: 10.7
Impact factor: 3.8
ISSN: 14787210, 17448336
PubMed ID:
23458769
Microbiology (medical)
Microbiology
Infectious Diseases
Virology
Abstract
In recent years, the Infectious Diseases Society of America has highlighted a faction of antibiotic-resistant bacteria (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp.) – acronymically dubbed ‘the ESKAPE pathogens’ – capable of ‘escaping’ the biocidal action of antibiotics and mutually representing new paradigms in pathogenesis, transmission and resistance. This review aims to consolidate clinically relevant background information on the ESKAPE pathogens and provide a contemporary summary of bacterial resistance, alongside pertinent microbiological considerations necessary to face the mounting threat of antimicrobial resistance.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
5
10
15
20
25
30
35
40
45
|
|
|
Antibiotics
41 publications, 3.43%
|
|
|
Scientific Reports
41 publications, 3.43%
|
|
|
Frontiers in Microbiology
34 publications, 2.84%
|
|
|
Antimicrobial Agents and Chemotherapy
24 publications, 2.01%
|
|
|
International Journal of Molecular Sciences
23 publications, 1.92%
|
|
|
Frontiers in Cellular and Infection Microbiology
18 publications, 1.51%
|
|
|
Microbiology spectrum
15 publications, 1.25%
|
|
|
Microorganisms
14 publications, 1.17%
|
|
|
PLoS ONE
13 publications, 1.09%
|
|
|
European Journal of Medicinal Chemistry
12 publications, 1%
|
|
|
Journal of Medicinal Chemistry
12 publications, 1%
|
|
|
ACS Infectious Diseases
11 publications, 0.92%
|
|
|
Molecules
10 publications, 0.84%
|
|
|
Nature Communications
10 publications, 0.84%
|
|
|
Bioorganic and Medicinal Chemistry Letters
10 publications, 0.84%
|
|
|
Journal of Antimicrobial Chemotherapy
10 publications, 0.84%
|
|
|
Microbial Drug Resistance
9 publications, 0.75%
|
|
|
BMC Microbiology
9 publications, 0.75%
|
|
|
Journal of Applied Microbiology
9 publications, 0.75%
|
|
|
mBio
9 publications, 0.75%
|
|
|
Microbial Pathogenesis
8 publications, 0.67%
|
|
|
Toxins
7 publications, 0.59%
|
|
|
Pathogens
7 publications, 0.59%
|
|
|
Pharmaceuticals
7 publications, 0.59%
|
|
|
Science of the Total Environment
7 publications, 0.59%
|
|
|
International Journal of Antimicrobial Agents
7 publications, 0.59%
|
|
|
RSC Advances
7 publications, 0.59%
|
|
|
Microbiology Resource Announcements
6 publications, 0.5%
|
|
|
Biomolecules
6 publications, 0.5%
|
|
|
5
10
15
20
25
30
35
40
45
|
Publishers
|
50
100
150
200
250
|
|
|
Elsevier
206 publications, 17.22%
|
|
|
Springer Nature
181 publications, 15.13%
|
|
|
MDPI
164 publications, 13.71%
|
|
|
American Society for Microbiology
81 publications, 6.77%
|
|
|
American Chemical Society (ACS)
72 publications, 6.02%
|
|
|
Frontiers Media S.A.
71 publications, 5.94%
|
|
|
Wiley
62 publications, 5.18%
|
|
|
Cold Spring Harbor Laboratory
57 publications, 4.77%
|
|
|
Taylor & Francis
46 publications, 3.85%
|
|
|
Oxford University Press
40 publications, 3.34%
|
|
|
Royal Society of Chemistry (RSC)
31 publications, 2.59%
|
|
|
Public Library of Science (PLoS)
19 publications, 1.59%
|
|
|
Mary Ann Liebert
17 publications, 1.42%
|
|
|
Microbiology Society
12 publications, 1%
|
|
|
Bentham Science Publishers Ltd.
12 publications, 1%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
5 publications, 0.42%
|
|
|
IntechOpen
5 publications, 0.42%
|
|
|
SAGE
4 publications, 0.33%
|
|
|
Walter de Gruyter
4 publications, 0.33%
|
|
|
Hindawi Limited
4 publications, 0.33%
|
|
|
Proceedings of the National Academy of Sciences (PNAS)
4 publications, 0.33%
|
|
|
Pleiades Publishing
3 publications, 0.25%
|
|
|
Cambridge University Press
3 publications, 0.25%
|
|
|
Canadian Science Publishing
2 publications, 0.17%
|
|
|
PeerJ
2 publications, 0.17%
|
|
|
AOSIS
2 publications, 0.17%
|
|
|
American Society for Biochemistry and Molecular Biology
2 publications, 0.17%
|
|
|
King Saud University
2 publications, 0.17%
|
|
|
Federation of American Societies for Experimental Biology (FASEB)
2 publications, 0.17%
|
|
|
50
100
150
200
250
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
1.2k
Total citations:
1196
Citations from 2025:
109
(9.11%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Pendleton J. N., Gorman S. P., Gilmore B. Clinical relevance of the ESKAPE pathogens // Expert Review of Anti-Infective Therapy. 2013. Vol. 11. No. 3. pp. 297-308.
GOST all authors (up to 50)
Copy
Pendleton J. N., Gorman S. P., Gilmore B. Clinical relevance of the ESKAPE pathogens // Expert Review of Anti-Infective Therapy. 2013. Vol. 11. No. 3. pp. 297-308.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1586/eri.13.12
UR - https://doi.org/10.1586/eri.13.12
TI - Clinical relevance of the ESKAPE pathogens
T2 - Expert Review of Anti-Infective Therapy
AU - Pendleton, Jack N
AU - Gorman, Sean P.
AU - Gilmore, Brendan
PY - 2013
DA - 2013/03/04
PB - Taylor & Francis
SP - 297-308
IS - 3
VL - 11
PMID - 23458769
SN - 1478-7210
SN - 1744-8336
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2013_Pendleton,
author = {Jack N Pendleton and Sean P. Gorman and Brendan Gilmore},
title = {Clinical relevance of the ESKAPE pathogens},
journal = {Expert Review of Anti-Infective Therapy},
year = {2013},
volume = {11},
publisher = {Taylor & Francis},
month = {mar},
url = {https://doi.org/10.1586/eri.13.12},
number = {3},
pages = {297--308},
doi = {10.1586/eri.13.12}
}
Cite this
MLA
Copy
Pendleton, Jack N., et al. “Clinical relevance of the ESKAPE pathogens.” Expert Review of Anti-Infective Therapy, vol. 11, no. 3, Mar. 2013, pp. 297-308. https://doi.org/10.1586/eri.13.12.